Lightchain Capital

Recent News

aiProteins_Final_logo300
November 03, 2022

AI Proteins Secures $18.2 Million Seed Round to Pioneer High-throughput Platform for Advanced Miniprotein Therapeutics

READ MORE
DCTX_FinalLogo_ColorAndWhite_forWebsite3
November 01, 2022

Atossa acquiring ~20% stake in Dynamic Cell Therapies to boost CAR-T development

READ MORE
CareVet-Logo-New
October 17, 2022

CareVet Deploys CareVet Rescue To Aid in Hurricane Ian Relief Efforts

READ MORE
CareVet-Logo-New
October 07, 2022

CareVet deploys CareVet Rescue to aid in Hurricane Ian relief efforts

READ MORE
Logo-Geneoscopy-400
October 04, 2022

Geneoscopy announces rebranding

READ MORE
Logo-Geneoscopy-400
October 03, 2022

Geneoscopy announces rebranding

READ MORE
C4-logo-400
September 29, 2022

C4 Therapeutics Receives Study May Proceed Letter from U.S. FDA to Initiate Phase 1/2 Clinical Trial of CFT1946, an Orally Bioavailable BiDAC™ Degrader, in BRAF-V600 Mutant Solid Cancers

READ MORE
Logo-Geneoscopy-400
September 27, 2022

Geneoscopy Completes Pivotal Colorectal Cancer Trial Enrollment with Diverse Participant Population

READ MORE
Logo-Geneoscopy-400
September 27, 2022

Geneoscopy Completes Pivotal Colorectal Cancer Trial Enrollment with Diverse Participant Population

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2024 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group